XANOMELINE AND TROSPIUM CHLORIDE

XANOMELINE AND TROSPIUM CHLORIDE was reported 2767 times

XANOMELINE AND TROSPIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ABNORMAL INVOLUNTARY MOVEMENT SCALE 1 0.3333
1 MACROPROLACTINAEMIA 1 0.1111
2 OESOPHAGEAL MUCOSAL BLISTER 1 0.0345
3 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 2 0.0299
4 ANTICHOLINERGIC EFFECT 2 0.0267
5 SCHIZOAFFECTIVE DISORDER DEPRESSIVE TYPE 1 0.0238
6 HYPERRESPONSIVE TO STIMULI 1 0.0159
7 DRUG TITRATION 2 0.0128
8 URTICARIA CHOLINERGIC 1 0.0105
9 FRONTAL LOBE EPILEPSY 1 0.0103
10 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 2 0.0087
11 DROOLING 58 0.0084
12 FUMBLING 1 0.0083
13 RESTLESS ARM SYNDROME 1 0.0064
14 SOCIOECONOMIC PRECARITY 1 0.0058
15 ANAEMIA OF PREGNANCY 1 0.0058
16 BLOOD PROLACTIN DECREASED 1 0.0057
17 PSYCHIATRIC DECOMPENSATION 11 0.0056
18 ANAL FISSURE HAEMORRHAGE 1 0.0054
19 INTRUSIVE THOUGHTS 6 0.0051
20 SENSORY OVERLOAD 1 0.0051
21 PRODUCT ADMINISTRATION ISSUE 1 0.0048
22 REBOUND PSYCHOSIS 1 0.0047
23 SOLILOQUY 4 0.0046
24 URINARY RETENTION 153 0.0046
25 SYMPATHOMIMETIC EFFECT 1 0.0043
26 SOMATIC DELUSION 1 0.0041
27 BLUNTED AFFECT 3 0.0041
28 DUODENOGASTRIC REFLUX 1 0.0036
29 OESOPHAGITIS HAEMORRHAGIC 1 0.0036
30 HALLUCINATION, AUDITORY 56 0.0035
31 LENS DISORDER 1 0.0035
32 VOMITING PROJECTILE 10 0.0035
33 DEFIANT BEHAVIOUR 1 0.0032
34 MUSCLE TONE DISORDER 1 0.0032
35 CHOLINERGIC SYNDROME 2 0.0031
36 SALIVARY HYPERSECRETION 31 0.0031
37 HALLUCINATION, TACTILE 2 0.0030
38 URINARY TRACT INFLAMMATION 1 0.0028
39 ANAESTHESIA 1 0.0027
40 OBSESSIVE-COMPULSIVE SYMPTOM 1 0.0027
41 AMPHETAMINES POSITIVE 2 0.0027
42 CARDIOVASCULAR SYMPTOM 1 0.0026
43 POVERTY OF SPEECH 1 0.0026
44 INAPPROPRIATE AFFECT 4 0.0025
45 ORGANIC ERECTILE DYSFUNCTION 1 0.0023
46 HALLUCINATION, OLFACTORY 1 0.0023
47 LOSS OF THERAPEUTIC RESPONSE 7 0.0022
48 HYPERSEXUALITY 4 0.0022
49 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
50 SCHIZOPHRENIA 26 0.0021
51 PSYCHOTIC DISORDER 62 0.0021
52 VERBAL ABUSE 1 0.0020
53 GENITAL ERYTHEMA 1 0.0020
54 LIBIDO INCREASED 4 0.0020
55 VIOLENCE-RELATED SYMPTOM 3 0.0019
56 URTICARIAL VASCULITIS 1 0.0019
57 GRIEF REACTION 1 0.0019
58 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
59 COATING IN MOUTH 1 0.0019
60 GASTROINTESTINAL TRACT IRRITATION 2 0.0018
61 PRESBYOPIA 1 0.0018
62 LAZINESS 3 0.0018
63 FLASHBACK 1 0.0017
64 TACHYPHRENIA 6 0.0017
65 ORTHOSTATIC HYPERTENSION 1 0.0017
66 UMBILICAL CORD AROUND NECK 1 0.0017
67 SCHIZOAFFECTIVE DISORDER 3 0.0017
68 URINARY HESITATION 4 0.0017
69 GRUNTING 1 0.0017
70 SEDATION COMPLICATION 4 0.0016
71 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
72 PNEUMONIA NECROTISING 1 0.0015
73 FACIAL DISCOMFORT 1 0.0014
74 MANIA 23 0.0014
75 JUDGEMENT IMPAIRED 2 0.0014
76 NEGATIVE THOUGHTS 4 0.0014
77 DELUSION 21 0.0014
78 ANOSOGNOSIA 1 0.0013
79 PARANOIA 22 0.0013
80 STARING 3 0.0012
81 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
82 TREATMENT NONCOMPLIANCE 65 0.0012
83 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
84 DYSPEPSIA 112 0.0011
85 BEHAVIOUR DISORDER 6 0.0011
86 MOTION SICKNESS 2 0.0010
87 HYPERVIGILANCE 1 0.0010
88 DRY MOUTH 82 0.0010
89 ANTISOCIAL BEHAVIOUR 1 0.0010
90 VOMITING 439 0.0009
91 BINGE EATING 1 0.0009
92 CONSTIPATION 202 0.0009
93 PILOERECTION 1 0.0009
94 CHRONIC GASTRITIS 2 0.0009
95 HALO VISION 1 0.0009
96 MOANING 1 0.0009
97 AKATHISIA 12 0.0009
98 FLAT AFFECT 2 0.0009
99 GAMBLING 1 0.0009
100 RECTAL ULCER 1 0.0009
101 VOLVULUS 2 0.0008
102 MYOPIA 2 0.0008
103 URINE FLOW DECREASED 2 0.0008
104 HALLUCINATION, VISUAL 17 0.0008
105 HOSTILITY 2 0.0008
106 OBSTRUCTION GASTRIC 1 0.0008
107 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
108 DRUG TITRATION ERROR 2 0.0008
109 BILIARY OBSTRUCTION 1 0.0008
110 GASTROOESOPHAGEAL REFLUX DISEASE 62 0.0008
111 LIBIDO DISORDER 1 0.0008
112 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
113 BRAIN FOG 12 0.0008
114 SEDATION 20 0.0008
115 HYPERHIDROSIS 97 0.0008
116 NAUSEA 593 0.0007
117 HOMICIDAL IDEATION 3 0.0007
118 INTESTINAL MASS 1 0.0007
119 DRUG SCREEN FALSE POSITIVE 2 0.0007
120 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
121 APPENDIX DISORDER 1 0.0007
122 DYSURIA 26 0.0007
123 GLUTEN SENSITIVITY 1 0.0007
124 GASTROINTESTINAL DISORDER 62 0.0007
125 MUTISM 1 0.0007
126 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
127 COLD SWEAT 12 0.0007
128 GENERALISED ANXIETY DISORDER 1 0.0007
129 GENITAL PAIN 1 0.0007
130 VISION BLURRED 92 0.0007
131 HEART RATE INCREASED 65 0.0007
132 DYSCHEZIA 2 0.0007
133 PNEUMONIA PSEUDOMONAL 1 0.0007
134 SUBSTANCE USE 1 0.0006
135 ADVERSE EVENT 59 0.0006
136 FOREIGN BODY IN THROAT 2 0.0006
137 DRUG SCREEN POSITIVE 5 0.0006
138 PHARYNGEAL PARAESTHESIA 1 0.0006
139 ANTICHOLINERGIC SYNDROME 1 0.0006
140 DISINHIBITION 1 0.0006
141 PHARYNGEAL SWELLING 6 0.0006
142 FOOD AVERSION 1 0.0006
143 MILIARIA 1 0.0006
144 PRIAPISM 2 0.0006
145 TREATMENT DELAYED 1 0.0006
146 DEPRESSION SUICIDAL 2 0.0006
147 MICTURITION DISORDER 2 0.0006
148 CATATONIA 3 0.0006
149 LOGORRHOEA 2 0.0006
150 DEPRESSIVE SYMPTOM 2 0.0006
151 FOOD INTERACTION 1 0.0006
152 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
153 PRODUCT SUPPLY ISSUE 4 0.0006
154 OVERWEIGHT 3 0.0006
155 OBSESSIVE THOUGHTS 1 0.0006
156 APATHY 8 0.0005
157 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
158 HYPOMANIA 2 0.0005
159 OESOPHAGEAL SPASM 1 0.0005
160 HOMICIDE 1 0.0005
161 PSYCHIATRIC SYMPTOM 4 0.0005
162 PUPILLARY REFLEX IMPAIRED 1 0.0005
163 HEART RATE ABNORMAL 3 0.0005
164 THINKING ABNORMAL 10 0.0005
165 BLADDER SPASM 1 0.0005
166 ANGER 18 0.0005
167 HYPERSOMNIA 15 0.0005
168 EARLY SATIETY 1 0.0005
169 MUCOSAL DRYNESS 1 0.0005
170 CARDIAC DISCOMFORT 1 0.0005
171 FOAMING AT MOUTH 1 0.0005
172 TACHYCARDIA 44 0.0005
173 ENURESIS 2 0.0005
174 HALLUCINATION 37 0.0005
175 HICCUPS 4 0.0005
176 COMPULSIVE SHOPPING 1 0.0005
177 IMPULSE-CONTROL DISORDER 1 0.0005
178 POLYCYTHAEMIA 1 0.0005
179 PHYSICAL ASSAULT 1 0.0005
180 BLEPHAROSPASM 3 0.0005
181 HALLUCINATIONS, MIXED 2 0.0005
182 HEPATIC PAIN 2 0.0005
183 ANURIA 4 0.0005
184 ACCIDENT AT WORK 1 0.0005
185 HYPERTENSIVE CRISIS 5 0.0004
186 TEMPERATURE REGULATION DISORDER 1 0.0004
187 FEAR OF DEATH 1 0.0004
188 URINARY TRACT DISORDER 2 0.0004
189 IMPAIRED GASTRIC EMPTYING 6 0.0004
190 EYE MOVEMENT DISORDER 3 0.0004
191 READING DISORDER 1 0.0004
192 PERFORMANCE STATUS DECREASED 2 0.0004
193 PRURITUS GENITAL 1 0.0004
194 WEIGHT ABNORMAL 1 0.0004
195 PULSE ABNORMAL 1 0.0004
196 WRONG DOSE 1 0.0004
197 SLOW SPEECH 1 0.0004
198 ACUTE PSYCHOSIS 1 0.0004
199 ABNORMAL BEHAVIOUR 16 0.0004
200 INABILITY TO AFFORD MEDICATION 4 0.0004
201 DYSKINESIA 16 0.0004
202 EUPHORIC MOOD 4 0.0004
203 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
204 BRUXISM 2 0.0004
205 ANORGASMIA 1 0.0004
206 TIC 2 0.0004
207 INCREASED APPETITE 7 0.0004
208 FAECALOMA 2 0.0004
209 CHOKING SENSATION 2 0.0004
210 CHOLECYSTITIS INFECTIVE 1 0.0004
211 DRUG TOLERANCE DECREASED 1 0.0004
212 PSYCHOMOTOR RETARDATION 1 0.0004
213 EJACULATION DISORDER 1 0.0004
214 RESPIRATORY SYMPTOM 1 0.0004
215 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
216 BILIARY COLIC 1 0.0003
217 MOVEMENT DISORDER 11 0.0003
218 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
219 SEXUAL DYSFUNCTION 4 0.0003
220 AGITATION 25 0.0003
221 ABDOMINAL DISCOMFORT 57 0.0003
222 AGGRESSION 17 0.0003
223 ENERGY INCREASED 2 0.0003
224 SUICIDAL IDEATION 31 0.0003
225 GALLBLADDER DISORDER 6 0.0003
226 ODYNOPHAGIA 2 0.0003
227 CRANIOCEREBRAL INJURY 1 0.0003
228 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
229 RETCHING 7 0.0003
230 MASTICATION DISORDER 1 0.0003
231 PRODUCT DISTRIBUTION ISSUE 3 0.0003
232 BLADDER PAIN 1 0.0003
233 SOMNOLENCE 63 0.0003
234 STUPOR 1 0.0003
235 SKIN EROSION 1 0.0003
236 INCOHERENT 2 0.0003
237 RESTLESSNESS 11 0.0003
238 POTENTIATING DRUG INTERACTION 1 0.0003
239 INITIAL INSOMNIA 3 0.0003
240 POLYMENORRHOEA 1 0.0003
241 PANIC REACTION 2 0.0003
242 OESOPHAGITIS 3 0.0003
243 FOOD INTOLERANCE 1 0.0003
244 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
245 FEELING DRUNK 2 0.0003
246 HYPERACUSIS 1 0.0003
247 THERAPY NON-RESPONDER 12 0.0003
248 IMPULSIVE BEHAVIOUR 1 0.0003
249 FEELING JITTERY 5 0.0003
250 INSURANCE ISSUE 4 0.0003
251 COMMUNICATION DISORDER 1 0.0003
252 DISSOCIATION 2 0.0003
253 MUSCLE TWITCHING 6 0.0003
254 OESOPHAGEAL DISORDER 1 0.0003
255 ERUCTATION 5 0.0003
256 PANIC DISORDER 1 0.0003
257 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
258 ADVERSE DRUG REACTION 23 0.0003
259 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
260 DIZZINESS 127 0.0003
261 PROSTATOMEGALY 1 0.0003
262 AFFECTIVE DISORDER 2 0.0003
263 PRODUCT USE COMPLAINT 4 0.0003
264 OESOPHAGEAL PAIN 1 0.0003
265 MENTAL DISORDER 11 0.0003
266 HYPERPHAGIA 1 0.0003
267 NIGHT SWEATS 8 0.0002
268 ABDOMINAL PAIN UPPER 51 0.0002
269 PRODUCT ADMINISTRATION ERROR 5 0.0002
270 TREMOR 41 0.0002
271 SUICIDAL BEHAVIOUR 1 0.0002
272 DYSARTHRIA 9 0.0002
273 INTESTINAL OBSTRUCTION 9 0.0002
274 SELF-INJURIOUS IDEATION 1 0.0002
275 URINARY INCONTINENCE 7 0.0002
276 TONGUE DISCOMFORT 1 0.0002
277 DYSPHAGIA 22 0.0002
278 HIATUS HERNIA 3 0.0002
279 HEPATIC LESION 1 0.0002
280 NIGHTMARE 8 0.0002
281 TONGUE DISCOLOURATION 1 0.0002
282 ANHEDONIA 6 0.0002
283 DYSPHEMIA 1 0.0002
284 HEAD DISCOMFORT 4 0.0002
285 THERAPY INTERRUPTED 16 0.0002
286 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
287 OFF LABEL USE 195 0.0002
288 WEIGHT DECREASED 62 0.0002
289 THROAT TIGHTNESS 6 0.0002
290 RESTLESS LEGS SYNDROME 4 0.0002
291 PRODUCT AVAILABILITY ISSUE 5 0.0002
292 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
293 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
294 BLOOD PRESSURE INCREASED 33 0.0002
295 HUNGER 3 0.0002
296 FEELING OF DESPAIR 1 0.0002
297 INSOMNIA 57 0.0002
298 YELLOW SKIN 1 0.0002
299 TARDIVE DYSKINESIA 6 0.0002
300 BLOOD PROLACTIN INCREASED 1 0.0002
301 STILLBIRTH 1 0.0002
302 GUILLAIN-BARRE SYNDROME 1 0.0002
303 PRESYNCOPE 5 0.0002
304 PARKINSONISM 2 0.0002
305 DISTURBANCE IN ATTENTION 11 0.0002
306 ANGIOEDEMA 9 0.0002
307 THERAPY CHANGE 2 0.0002
308 DRY EYE 10 0.0002
309 IRRITABILITY 12 0.0002
310 DRUG TOLERANCE 1 0.0002
311 HYPOTHERMIA 2 0.0002
312 EYELID PTOSIS 2 0.0002
313 PALPITATIONS 23 0.0002
314 SLUGGISHNESS 2 0.0002
315 HYPOPHAGIA 5 0.0002
316 ILLNESS 20 0.0002
317 TRISMUS 1 0.0002
318 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
319 PANIC ATTACK 7 0.0002
320 GASTRITIS 5 0.0002
321 BLOOD LACTIC ACID INCREASED 1 0.0002
322 CHEST PAIN 35 0.0002
323 EATING DISORDER 4 0.0002
324 DRUG INTOLERANCE 18 0.0002
325 HYPERTENSION 39 0.0002
326 BIPOLAR DISORDER 2 0.0002
327 ASPIRATION 2 0.0002
328 ABNORMAL DREAMS 5 0.0002
329 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
330 PERIORBITAL SWELLING 1 0.0002
331 HEPATIC ENZYME INCREASED 12 0.0002
332 LETHARGY 10 0.0002
333 EXERCISE TOLERANCE DECREASED 1 0.0002
334 METABOLIC DISORDER 1 0.0002
335 SKIN WARM 1 0.0002
336 URINE ODOUR ABNORMAL 1 0.0002
337 SLEEP DISORDER 12 0.0002
338 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
339 HOSPITALISATION 25 0.0002
340 LARYNGEAL OEDEMA 1 0.0002
341 EMOTIONAL DISORDER 5 0.0002
342 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
343 EXTRAPYRAMIDAL DISORDER 4 0.0002
344 NASAL DRYNESS 1 0.0002
345 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
346 POST-TRAUMATIC STRESS DISORDER 1 0.0001
347 PRODUCT PHYSICAL ISSUE 3 0.0001
348 FEEDING DISORDER 3 0.0001
349 TASTE DISORDER 3 0.0001
350 BODY TEMPERATURE INCREASED 3 0.0001
351 FEELING HOT 9 0.0001
352 FEELING ABNORMAL 35 0.0001
353 FORMICATION 1 0.0001
354 CONFUSIONAL STATE 23 0.0001
355 DYSPHONIA 8 0.0001
356 BLINDNESS TRANSIENT 1 0.0001
357 NERVOUSNESS 7 0.0001
358 BREAST TENDERNESS 1 0.0001
359 TROPONIN INCREASED 1 0.0001
360 FOOD ALLERGY 1 0.0001
361 DECREASED APPETITE 30 0.0001
362 CONCUSSION 1 0.0001
363 COGNITIVE DISORDER 6 0.0001
364 SWOLLEN TONGUE 4 0.0001
365 GASTROINTESTINAL INFLAMMATION 1 0.0001
366 BLOOD ALBUMIN DECREASED 1 0.0001
367 RENAL CYST 1 0.0001
368 GINGIVAL PAIN 1 0.0001
369 MOOD SWINGS 4 0.0001
370 BLOOD DISORDER 1 0.0001
371 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
372 FRUSTRATION TOLERANCE DECREASED 1 0.0001
373 POLYURIA 1 0.0001
374 VISUAL IMPAIRMENT 15 0.0001
375 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
376 POLLAKIURIA 5 0.0001
377 CHILLS 14 0.0001
378 UNRESPONSIVE TO STIMULI 3 0.0001
379 THERAPEUTIC RESPONSE DECREASED 7 0.0001
380 DELIRIUM 4 0.0001
381 ORTHOSTATIC HYPOTENSION 2 0.0001
382 VERTIGO 7 0.0001
383 SPEECH DISORDER 6 0.0001
384 URINE OUTPUT DECREASED 1 0.0001
385 GROIN PAIN 1 0.0001
386 THIRST 2 0.0001
387 ANAL INCONTINENCE 1 0.0001
388 HEAVY MENSTRUAL BLEEDING 1 0.0001
389 TOOTHACHE 2 0.0001
390 MOOD ALTERED 3 0.0001
391 PATHOGEN RESISTANCE 1 0.0001
392 ACCIDENTAL OVERDOSE 4 0.0001
393 BRAIN NEOPLASM 1 0.0001
394 PERSONALITY CHANGE 1 0.0001
395 DIARRHOEA HAEMORRHAGIC 1 0.0001
396 LEUKAEMIA 1 0.0001
397 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
398 ABDOMINAL DISTENSION 11 0.0001
399 BALANCE DISORDER 9 0.0001
400 AFFECT LABILITY 1 0.0001
401 SEIZURE 12 0.0001
402 DIZZINESS POSTURAL 1 0.0001
403 DYSSTASIA 3 0.0001
404 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
405 CHOKING 2 0.0001
406 BLADDER DISORDER 1 0.0001
407 VAGINAL DISCHARGE 1 0.0001
408 EXTRA DOSE ADMINISTERED 4 0.0001
409 WEIGHT INCREASED 22 0.0001
410 MOTOR DYSFUNCTION 1 0.0001
411 DEHYDRATION 13 0.0001
412 EAR DISCOMFORT 1 0.0001
413 LIMB DISCOMFORT 3 0.0001
414 PRODUCT ODOUR ABNORMAL 1 0.0001
415 FOLLICULITIS 1 0.0001
416 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
417 ANXIETY 27 0.0001
418 INCONTINENCE 1 0.0001
419 IMPAIRED WORK ABILITY 2 0.0001
420 LIVER FUNCTION TEST INCREASED 2 0.0001
421 DECREASED ACTIVITY 1 0.0001
422 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
423 MENSTRUATION DELAYED 1 0.0001
424 SKIN LACERATION 1 0.0001
425 PRODUCT PRESCRIBING ISSUE 2 0.0001
426 GASTROINTESTINAL PAIN 1 0.0001
427 FOOT DEFORMITY 1 0.0001
428 LIVER DISORDER 4 0.0001
429 OCULAR DISCOMFORT 1 0.0001
430 FLATULENCE 5 0.0001
431 MUSCULAR WEAKNESS 10 0.0001
432 IMPAIRED DRIVING ABILITY 1 0.0001
433 DEPRESSION 20 0.0001
434 MICTURITION URGENCY 1 0.0001
435 TINNITUS 4 0.0001
436 DIARRHOEA 56 0.0001
437 ABDOMINAL PAIN 20 0.0001
438 RASH MACULAR 3 0.0001
439 CONDITION AGGRAVATED 26 0.0001
440 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
441 COMPLETED SUICIDE 7 0.0001
442 PRODUCT PRESCRIBING ERROR 2 0.0001
443 ACCIDENT 1 0.0001
444 MUSCLE RIGIDITY 1 0.0001
445 WRIST FRACTURE 1 0.0001
446 BLOOD GLUCOSE DECREASED 4 0.0001
447 MUSCLE SPASTICITY 1 0.0001
448 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
449 SMALL INTESTINAL OBSTRUCTION 1 0.0001
450 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
451 ILEUS 1 0.0001
452 MEMORY IMPAIRMENT 11 0.0001
453 SECRETION DISCHARGE 1 0.0001
454 HOT FLUSH 6 0.0001
455 HAEMATEMESIS 2 0.0001
456 HEADACHE 49 0.0001
457 MYDRIASIS 1 0.0001
458 URINARY TRACT INFECTION 13 0.0001
459 BEDRIDDEN 1 0.0001
460 FATIGUE 58 0.0001
461 GAIT DISTURBANCE 14 0.0001
462 HAEMATOCHEZIA 4 0.0001
463 COORDINATION ABNORMAL 1 0.0001
464 APHONIA 1 0.0001
465 BLOOD TEST ABNORMAL 1 0.0001
466 PARAESTHESIA ORAL 1 0.0001
467 VAGINAL HAEMORRHAGE 3 0.0001
468 PRODUCT DOSE OMISSION ISSUE 20 0.0001
469 COLON CANCER 1 0.0001
470 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
471 HYPOAESTHESIA 10 0.0001
472 HYPOAESTHESIA ORAL 1 0.0001
473 APHASIA 2 0.0001
474 DISCOMFORT 4 0.0001
475 NERVOUS SYSTEM DISORDER 2 0.0001
476 DRUG INEFFECTIVE 84 0.0001
477 RESPIRATORY TRACT CONGESTION 1 0.0001
478 CYSTITIS 2 0.0001
479 OBESITY 1 0.0001
480 MUSCLE TIGHTNESS 1 0.0001
481 MALAISE 27 0.0001
482 BACK DISORDER 1 0.0001
483 BLOOD CREATININE INCREASED 4 0.0001
484 CHOLELITHIASIS 2 0.0001
485 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
486 GAIT INABILITY 2 0.0001
487 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
488 CHEST DISCOMFORT 6 0.0001
489 THERAPY CESSATION 3 0.0001
490 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
491 PRODUCT STORAGE ERROR 5 0.0001
492 HEART RATE DECREASED 2 0.0001
493 PANCREATITIS 3 0.0001
494 DEPRESSED MOOD 3 0.0001
495 GASTROENTERITIS VIRAL 1 0.0001
496 BLOOD GLUCOSE ABNORMAL 1 0.0001
497 AGRANULOCYTOSIS 1 0.0001
498 HEPATIC STEATOSIS 1 0.0001
499 NECK PAIN 3 0.0001
500 HEPATIC CIRRHOSIS 1 0.0001
501 BLOOD URINE PRESENT 1 0.0001
502 SLEEP APNOEA SYNDROME 1 0.0001
503 SEROTONIN SYNDROME 1 0.0001
504 PRESCRIBED OVERDOSE 1 0.0001
505 DYSTONIA 1 0.0001
506 HAEMORRHOIDS 1 0.0001
507 KIDNEY INFECTION 1 0.0001
508 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
509 ASTHENIA 19 0.0001
510 DISORIENTATION 2 0.0001
511 RASH 22 0.0001
512 DRUG INTERACTION 8 0.0001
513 FLUSHING 5 0.0000
514 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
515 WITHDRAWAL SYNDROME 2 0.0000
516 INTENTIONAL OVERDOSE 3 0.0000
517 IRRITABLE BOWEL SYNDROME 1 0.0000
518 HYPOACUSIS 2 0.0000
519 POOR QUALITY SLEEP 1 0.0000
520 FAECES DISCOLOURED 1 0.0000
521 SWELLING FACE 3 0.0000
522 PRODUCT DISPENSING ERROR 1 0.0000
523 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
524 TOOTH DISORDER 1 0.0000
525 THROAT IRRITATION 2 0.0000
526 CHROMATURIA 1 0.0000
527 SKIN DISCOLOURATION 2 0.0000
528 OROPHARYNGEAL PAIN 4 0.0000
529 HYPERSENSITIVITY 8 0.0000
530 MIGRAINE 4 0.0000
531 URTICARIA 7 0.0000
532 MENTAL IMPAIRMENT 1 0.0000
533 FIBROMYALGIA 1 0.0000
534 EPISTAXIS 3 0.0000
535 AGEUSIA 1 0.0000
536 PNEUMONIA ASPIRATION 1 0.0000
537 SYNCOPE 4 0.0000
538 PERIPHERAL SWELLING 6 0.0000
539 DRUG RESISTANCE 1 0.0000
540 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
541 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
542 EAR INFECTION 1 0.0000
543 FEAR 1 0.0000
544 RASH PRURITIC 2 0.0000
545 PALLOR 1 0.0000
546 SKIN LESION 1 0.0000
547 INFLUENZA LIKE ILLNESS 3 0.0000
548 ANAPHYLACTIC REACTION 2 0.0000
549 MENTAL STATUS CHANGES 1 0.0000
550 FEELING COLD 1 0.0000
551 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
552 DEMENTIA 1 0.0000
553 BLISTER 2 0.0000
554 OXYGEN SATURATION DECREASED 2 0.0000
555 PAIN IN JAW 1 0.0000
556 INTENTIONAL DOSE OMISSION 1 0.0000
557 RED BLOOD CELL COUNT DECREASED 1 0.0000
558 ANGINA PECTORIS 1 0.0000
559 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
560 MUSCULOSKELETAL STIFFNESS 3 0.0000
561 LABORATORY TEST ABNORMAL 1 0.0000
562 RESPIRATORY DISORDER 1 0.0000
563 LACRIMATION INCREASED 1 0.0000
564 EMOTIONAL DISTRESS 4 0.0000
565 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
566 SUICIDE ATTEMPT 2 0.0000
567 EPILEPSY 1 0.0000
568 GYNAECOMASTIA 1 0.0000
569 CARDIAC DISORDER 3 0.0000
570 PRODUCT USE ISSUE 6 0.0000
571 PARAESTHESIA 5 0.0000
572 LOSS OF CONSCIOUSNESS 4 0.0000
573 RHINORRHOEA 2 0.0000
574 BLOOD PRESSURE DECREASED 2 0.0000
575 DYSPNOEA 17 0.0000
576 LIP SWELLING 1 0.0000
577 HYPOTENSION 6 0.0000
578 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
579 BURNING SENSATION 2 0.0000
580 LYMPHADENOPATHY 1 0.0000
581 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
582 CRYING 1 0.0000
583 C-REACTIVE PROTEIN INCREASED 1 0.0000
584 MUSCLE SPASMS 5 0.0000
585 DYSGEUSIA 2 0.0000
586 HEPATIC FUNCTION ABNORMAL 1 0.0000
587 COLITIS 1 0.0000
588 ACNE 2 0.0000
589 BLINDNESS 1 0.0000
590 ROAD TRAFFIC ACCIDENT 1 0.0000
591 OSTEOARTHRITIS 1 0.0000
592 PRURITUS 9 0.0000
593 OVERDOSE 5 0.0000
594 INTENTIONAL PRODUCT MISUSE 2 0.0000
595 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
596 HYPOKALAEMIA 1 0.0000
597 RENAL DISORDER 1 0.0000
598 SWELLING 2 0.0000
599 ARRHYTHMIA 1 0.0000
600 PRODUCTIVE COUGH 1 0.0000
601 RASH ERYTHEMATOUS 1 0.0000
602 HYPOGLYCAEMIA 1 0.0000
603 PYREXIA 7 0.0000
604 CELLULITIS 1 0.0000
605 INFLAMMATION 1 0.0000
606 FALL 6 0.0000
607 INFLUENZA 2 0.0000
608 HYPONATRAEMIA 1 0.0000
609 EYE PAIN 1 0.0000
610 CEREBROVASCULAR ACCIDENT 3 0.0000
611 MYALGIA 3 0.0000
612 COVID-19 3 0.0000
613 NASAL CONGESTION 1 0.0000
614 WHEEZING 1 0.0000
615 CATARACT 1 0.0000
616 STOMATITIS 1 0.0000
617 NASOPHARYNGITIS 3 0.0000
618 BLOOD GLUCOSE INCREASED 3 0.0000
619 AMNESIA 1 0.0000
620 ALOPECIA 3 0.0000
621 DEATH 13 0.0000
622 RENAL FAILURE 2 0.0000
623 DRY SKIN 2 0.0000
624 NEUTROPENIA 2 0.0000
625 COUGH 4 0.0000
626 INJURY 1 0.0000
627 SKIN BURNING SENSATION 1 0.0000
628 MOBILITY DECREASED 1 0.0000
629 RESPIRATORY FAILURE 1 0.0000
630 UNEVALUABLE EVENT 1 0.0000
631 INCORRECT DOSE ADMINISTERED 3 0.0000
632 BACK PAIN 3 0.0000
633 TREATMENT FAILURE 1 0.0000
634 DRUG ABUSE 1 0.0000
635 TOXICITY TO VARIOUS AGENTS 2 0.0000
636 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
637 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
638 NO ADVERSE EVENT 2 0.0000
639 NEUROPATHY PERIPHERAL 1 0.0000
640 CONTUSION 1 0.0000
641 ERYTHEMA 2 0.0000
642 HAEMORRHAGE 1 0.0000
643 PLATELET COUNT DECREASED 1 0.0000
644 SEPSIS 1 0.0000
645 ASTHMA 1 0.0000
646 PAIN 5 0.0000
647 PRODUCT QUALITY ISSUE 1 0.0000
648 INFECTION 1 0.0000
649 DRUG DEPENDENCE 1 0.0000
650 MYOCARDIAL INFARCTION 1 0.0000
651 ANAEMIA 1 0.0000
652 ARTHRALGIA 2 0.0000
653 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
654 PAIN IN EXTREMITY 1 0.0000
655 PNEUMONIA 1 0.0000